Literature DB >> 22751534

Antibacterial properties of an oligo-acyl-lysyl hexamer targeting Gram-negative species.

Fadia Zaknoon1, Keren Goldberg, Hadar Sarig, Raquel F Epand, Richard M Epand, Amram Mor.   

Abstract

Toward developing new tools for fighting resistance to antibiotics, we investigated the antibacterial properties of a new decanoyl-based oligo-acyl-lysyl (OAK) hexamer, aminododecanoyl-lysyl-[aminodecanoyl-lysyl](5) (α(12)-5α(10)). The OAK exhibited preferential activity against Gram-negative bacteria (GNB), as determined using 36 strains, including diverse species, with an MIC(90) of 6.2 μM. The OAK's bactericidal mode of action was associated with rapid membrane depolarization and cell permeabilization, suggesting that the inner membrane was the primary target, whereas the observed binding affinity to lipoteichoic acid suggested that inefficacy against Gram-positive species resulted from a cell wall interaction preventing α(12)-5α(10) from reaching internal targets. Interestingly, perturbation of the inner membrane structure and function was preserved at sub-MIC values. This prompted us to assess the OAK's effect on the proton motive force-dependent efflux pump AcrAB-TolC, implicated in the low sensitivity of GNB to various antibiotics, including erythromycin. We found that under sub-MIC conditions, wild-type Escherichia coli was significantly more sensitive to erythromycin (the MIC dropped by >10-fold), unlike its acr-deletion mutant. Collectively, the data suggest a useful approach for treating GNB infections through overcoming antibiotic efflux.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751534      PMCID: PMC3421859          DOI: 10.1128/AAC.00511-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation.

Authors:  Anja Schumacher; Rainer Trittler; Jürgen A Bohnert; Klaus Kümmerer; Jean-Marie Pagès; Winfried V Kern
Journal:  J Antimicrob Chemother       Date:  2006-09-13       Impact factor: 5.790

Review 2.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.

Authors:  Robert E W Hancock; Hans-Georg Sahl
Journal:  Nat Biotechnol       Date:  2006-12       Impact factor: 54.908

3.  Synergistic interaction between proton pump inhibitors and resistance modifiers: promoting effects of antibiotics and plasmid curing.

Authors:  Kristina Wolfart; Gabriella Spengler; Masami Kawase; Noboru Motohashi; Joseph Molnár; Miguel Viveiros; Leonard Amaral
Journal:  In Vivo       Date:  2006 May-Jun       Impact factor: 2.155

4.  Improved antimicrobial peptides based on acyl-lysine oligomers.

Authors:  Inna S Radzishevsky; Shahar Rotem; Dmitry Bourdetsky; Shiri Navon-Venezia; Yehuda Carmeli; Amram Mor
Journal:  Nat Biotechnol       Date:  2007-05-27       Impact factor: 54.908

5.  Design and characterization of a broad -spectrum bactericidal acyl-lysyl oligomer.

Authors:  Liran Livne; Tchelet Kovachi; Hadar Sarig; Raquel F Epand; Fadia Zaknoon; Richard M Epand; Amram Mor
Journal:  Chem Biol       Date:  2009-12-24

6.  Structure-activity relationships of antibacterial acyl-lysine oligomers.

Authors:  Inna S Radzishevsky; Tchelet Kovachi; Yaara Porat; Lior Ziserman; Fadia Zaknoon; Dganit Danino; Amram Mor
Journal:  Chem Biol       Date:  2008-04

7.  Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa.

Authors:  Nityakalyani Srinivas; Peter Jetter; Bernhard J Ueberbacher; Martina Werneburg; Katja Zerbe; Jessica Steinmann; Benjamin Van der Meijden; Francesca Bernardini; Alexander Lederer; Ricardo L A Dias; Pauline E Misson; Heiko Henze; Jürg Zumbrunn; Frank O Gombert; Daniel Obrecht; Peter Hunziker; Stefan Schauer; Urs Ziegler; Andres Käch; Leo Eberl; Kathrin Riedel; Steven J DeMarco; John A Robinson
Journal:  Science       Date:  2010-02-19       Impact factor: 47.728

8.  Analogous oligo-acyl-lysines with distinct antibacterial mechanisms.

Authors:  Shahar Rotem; Inna S Radzishevsky; Dmitry Bourdetsky; Shiri Navon-Venezia; Yehuda Carmeli; Amram Mor
Journal:  FASEB J       Date:  2008-04-02       Impact factor: 5.191

9.  De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers.

Authors:  Sungwook Choi; Andre Isaacs; Dylan Clements; Dahui Liu; Hyemin Kim; Richard W Scott; Jeffrey D Winkler; William F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

10.  Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.

Authors:  Siegbert Rieg; Anja Huth; Hubert Kalbacher; Winfried V Kern
Journal:  Int J Antimicrob Agents       Date:  2008-10-21       Impact factor: 5.283

View more
  3 in total

Review 1.  Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs.

Authors:  Natalia Molchanova; Paul R Hansen; Henrik Franzyk
Journal:  Molecules       Date:  2017-08-29       Impact factor: 4.411

2.  Adaptation of Salmonella enterica Serovar Senftenberg to Linalool and Its Association with Antibiotic Resistance and Environmental Persistence.

Authors:  Emmanuel Kalily; Amit Hollander; Ben Korin; Itamar Cymerman; Sima Yaron
Journal:  Appl Environ Microbiol       Date:  2017-05-01       Impact factor: 4.792

3.  Antibacterial property of Ag nanoparticle-impregnated N-doped titania films under visible light.

Authors:  Ming-Show Wong; Chun-Wei Chen; Chia-Chun Hsieh; Shih-Che Hung; Der-Shan Sun; Hsin-Hou Chang
Journal:  Sci Rep       Date:  2015-07-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.